STOCK TITAN

Acutus Medical to Announce Fourth Quarter and Full-Year Financial Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Acutus Medical (Nasdaq: AFIB) will announce its Q4 and full-year 2021 financial results on March 17, 2022. The announcement will be followed by a conference call at 1:30 PM PT to discuss the results and recent highlights. Interested parties can join via telephone or live webinar. Acutus, based in Carlsbad, California, is committed to improving the diagnosis and treatment of cardiac arrhythmias through innovative products and technologies.

Positive
  • None.
Negative
  • None.

CARLSBAD, Calif., March 10, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that it will release its fourth quarter and full-year 2021 financial results on Thursday, March 17, 2022. In conjunction with the release, Acutus will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.

Interested parties may access the live call via telephone by dialing (833) 570-1131 for domestic callers or (914) 987-7078 for international callers, using conference ID: 4985645. The live webinar of the call may be accessed by visiting the Events section of the Acutus investor relations website at ir.acutusmedical.com. A replay of the webinar will be available shortly after the conclusion of the call and will be archived on the company’s website.

About Acutus Medical, Inc.
Acutus is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. Acutus is committed to advancing the field of electrophysiology with a unique array of products and technologies which will enable more physicians to treat more patients more efficiently and effectively. Through internal product development, acquisitions and global partnerships, Acutus has established a global sales presence delivering a broad portfolio of highly differentiated electrophysiology products that provide its customers with a complete solution for catheter-based treatment of cardiac arrhythmias. Founded in 2011, Acutus is based in Carlsbad, California.

Investor Contact:
Caroline Corner
ICR Westwicke
D: 415-202-5678
caroline.corner@westwicke.com

Holly Windler
M: 619-929-1275
media@acutusmedical.com


FAQ

When will Acutus Medical release its Q4 2021 financial results?

Acutus Medical will release its Q4 2021 financial results on March 17, 2022.

What time is the conference call for Acutus Medical's earnings release?

The conference call for Acutus Medical's earnings release is scheduled for 1:30 PM PT on March 17, 2022.

How can I access the Acutus Medical earnings conference call?

You can access the Acutus Medical earnings conference call by dialing (833) 570-1131 for domestic calls or (914) 987-7078 for international calls, using conference ID: 4985645.

Where can I find the replay of Acutus Medical's earnings call?

The replay of Acutus Medical's earnings call will be available shortly after the call on the company's investor relations website.

ACUTUS MEDICAL INC

OTC:AFIB

AFIB Rankings

AFIB Latest News

AFIB Stock Data

1.77M
27.23M
8.98%
0.01%
1.86%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
CARLSBAD